Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission
article
OA: closed
CC0
⤵ 59 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the relationship between Dienogest treatment and deep infiltrating endometriosis nodules, finding symptom remission did not correlate with nodule remission.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- Aspectos epidemiológicos e clínicos da endometriose pélvica: uma série de casos via openalex
- Deep endometriosis: definition, diagnosis, and treatment via openalex
- Deep Infiltrating Endometriosis Treatment with Dienogest: A Pilot Study via openalex
- Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis via openalex
- Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis via openalex
- Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis via openalex
- Dienogest via openalex
- Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
- Dienogest for the treatment of deep endometriosis: Case report and literature review via openalex
- Dienogest in long-term treatment of endometriosis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex
- Endometriosis and Infertility via openalex
- Endometriosis Fertility Index ou classification de l’American Society of Reproductive Medicine pour les patientes infertiles endométriosiques opérées. Lequel est le plus pertinent ? via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
- Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- Ultrasound mapping system for the surgical management of deep infiltrating endometriosis via openalex
- Use of dienogest over 53 weeks for the treatment of endometriosis via openalex
- Validação da Versão Portuguesa do Questionário EHP-30 (The Endometriosis Health Profile-30) via openalex
- What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis via openalex
- W2060765936 via openalex
- W2153037374 via openalex
- W2045458073 via openalex
- W2021687464 via openalex
- W2170519509 via openalex
- W2429180991 via openalex
- W78459228 via openalex
- W1516382093 via openalex
- W3028409625 via openalex
- W4211081176 via openalex
- W4285719527 via openalex
- W6604636690 via openalex
- W6638359506 via openalex
- W2132577372 via openalex
- W6646927974 via openalex
Cited by (50)
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment 2025
- Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review 2025
- Deeply Infiltrating Endometriosis (DIE) No More: Dienogest as a Game Changer in Rectovaginal Endometriosis 2025
- Conservative Management of Bowel Endometriosis: Cross-Sectional Analysis for Assessing Clinical Outcomes and Quality-of-Life 2024
- Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis 2024
- Outpatient diagnosis and drug therapy of endometriosis: A review 2024
- Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles 2023
- In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain 2023
- DOES BOWEL FUNCTION IMPACTS ON QUALITY OF LIFE AND SEXUAL FUNCTION IN WOMEN WITH DEEP INFILTRATING ENDOMETRIOSIS ACCORDING KIND OF TREATMENT? 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Effects of metformin and ganirelix on subcutaneous endometriosis in a mouse model of autophagy-related cell death 2023
- Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis 2023
- The role of gut dysbiosis in endometriosis’ diagnosis and treatment approaches – case report 2023
- Tratamento clínico de endometriose profunda com uso de droga antiproliferativa (metotrexato) acoplado a nanoemulsão lipídica (LDE) 2023
- Update on the management of endometriosis-associated pain in France 2023
- Progesterone receptor ligands for the treatment of endometriosis 2022
- Pelvic pain and psychoemotional status in women with ovarian endometrioma combined with pelvic inflammatory diseases: treatment options choice 2022
- Application of Dienogest In the Treatment of Endometriosis 2022
- Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN 2022
- Hormonal drugs for the treatment of endometriosis 2022
- Pharmacological correction of immunometabolic disorders in patients with endometrioma along with chronic inflammatory diseases of the genital tract 2022
- Treatment of endometriosis with dienogest in combination with traditional Chinese medicine: A systematic review and meta-analysis 2022
- Estradiol/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis 2021
- Disfunções pélvicas em mulheres com endometriose profunda 2021
- Endometriosis Pathology Outline 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
- Ovarian endometriosis and fertility preservation problem 2021
- Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review 2021
- POSSIBILITIES OF PERSONIFIED TREATMENT TACTICS IN PATIENTS WITH PROLIFERATIVE DISEASES OF THE GENITALS AND CHRONIC PELVIC PAIN 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Endometrial thickness in the evaluation of clinical response to medical treatment for deep infiltrating endometriosis: a retrospective study 2020
- Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis 2020
- Dienogest treatment improves quality of life in women with endometriosis: A prospective cohort study 2020
- Hormonal Treatment of Bowel Endometriosis 2020
- BENEFÍCIOS DO USO DE DIENOGEST NO TRATAMENTO DA ENDOMETRIOSE 2020
- Use of dienogest in endometriosis: a narrative literature review and expert commentary 2020
- <p>Bowel Endometriosis: Current Perspectives on Diagnosis and Treatment</p> 2020
- Quality of Life in Women with Deep Endometriosis: A Cross-Sectional Study 2020
- Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis 2020
- MODERN STRATEGY FOR THE MANAGEMENT OF CHRONIC PELVIC PAIN IN WOMEN WITH COMBINATIONS OF BENIGN UTERINE DISEASES 2019
- Endometriotic lesions 2019
- Systematic review of quality of life measures in patients with endometriosis 2019
- Medical treatment in the management of deep endometriosis infiltrating the proximal rectum and sigmoid colon: a comprehensive literature review 2018
- Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science 2018
- When Solving Dyspareunia Is Not Enough to Restore Sexual Function in Women With Deep Infiltrating Endometriosis Treated With Dienogest 2018
- Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice 2018
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T16:23:13.998983+00:00
- pubmed
- last seen: 2026-05-13T22:20:37.704673+00:00
License: CC0
· commercial use OK